Cannabis
Cannabis is a roughly $50B global legal market across medical and recreational adult-use, with the US accounting for over half despite federal-level illegality. The US legal market is fragmented across multi-state operators (MSOs) given each state runs its own licensing regime; Canadian operators (Aurora, Canopy and Tilray) overbuilt during the 2018-19 enthusiasm and most have since written down significantly. Federal rescheduling from Schedule I to Schedule III (under DEA review since 2024) and SAFER Banking reform remain the principal regulatory unlocks.
It spans recreational adult-use flower and pre-rolls, edibles and beverages, vaporisers and concentrates, medical cannabis (THC and CBD), hemp-derived products and the ancillary infrastructure (testing, packaging, software) around the category.
Revenue comes from wholesale flower and product distribution to dispensaries, owned retail dispensary sales, branded consumer product sales, licensing of cultivation and processing IP, and ancillary services around the regulated cannabis industry.
Cannabis is part of Consumer products.
$70B
Global market size
50
Public companies
Key VC investors
Key strategic buyers
How cannabis companies monetize?
Cannabis companies monetize through vertically integrated cultivation-retail, branded CPG positioning and wholesale or brand licensing.
Vertically integrated cultivation, processing, retail
MSOs operate licensed cultivation, processing and retail in each state. Curaleaf, Trulieve, Verano and Cresco Labs use this model.
Branded CPG positioning
Branded edibles, beverages and vapes sold through dispensaries. Cookies, Wana and Wyld (Curaleaf) compete in branded edibles.
Wholesale and brand licensing
Wholesale flower and concentrate to dispensaries plus brand licensing across states. Stiiizy and Cookies use this model heavily.
Medical cannabis distribution
Per-prescription or membership models for medical cannabis. Important in Germany (post-April 2024 legalisation) and Florida.
Hemp and CBD products
Hemp-derived CBD and consumer products. Charlotte's Web (TSX: CWEB) and CBDfx lead consumer CBD; legal grey area persists across markets.
Ancillary services
Cultivation tech, testing labs, packaging and software for the regulated industry. Distinct from THC-touching businesses with cleaner regulatory profile.
Cannabis valuations in May 2026
Public cannabis comps trade at 0.9x EV/Revenue. Median revenue multiple across cannabis M&A deals was 1.4x in the last 12 months.
0.9x
Median EV/Revenue as of May 2026 for public cannabis companies
n/m
Curaleaf is the highest valued public cannabis company based on EV/Revenue (excluding outliers)
1.4x
Median EV/Revenue across cannabis M&A deals in the last 12 months
-
Median EV/Revenue across cannabis VC rounds in the last 12 months
Cannabis market segments
Major cannabis segments include US multi-state operators, Canadian licensed producers and branded edibles and beverages.
US multi-state operators (MSOs)
Vertically integrated companies operating cultivation-processing-retail across multiple US states. Curaleaf (CSE: CURA), Trulieve (CSE: TRUL), Verano (CSE: VRNO) and Cresco Labs (CSE: CL) lead by revenue.
Canadian LPs (licensed producers)
Federally licensed cultivators serving the Canadian recreational and medical markets. Tilray (NASDAQ: TLRY), Canopy Growth (NASDAQ: CGC), Aurora (NASDAQ: ACB) and Cronos (NASDAQ: CRON) dominate; most have written down significantly post-2019 overbuild.
Recreational dispensaries
Licensed retail outlets in adult-use states (US) and Canadian provinces. Native Roots, Garden Society, Sunnyside (Cresco) and Trulieve Stores are notable; many MSOs own retail directly.
Branded edibles and beverages
Cannabis-infused edibles, drinks and concentrates. Cookies, Wyld (Curaleaf), Wana and Tinley compete in branded edibles; cannabis beverages (Cann, Lagunitas Hi-Fi Hops, BellRose and Hi-Five) growing slowly.
Hemp and CBD
Hemp-derived consumer products outside the THC framework. Charlotte's Web, CBDfx, Cornbread Hemp and Joy Organics lead; category persistently challenged by regulatory ambiguity.
Ancillary infrastructure
Cultivation tech, packaging, testing labs and software (METRC track-and-trace mandates). Urban-gro, Hydrofarm, Steep Hill labs and Dutchie compete.
Fractional CFO, financial modelling and deal advice for cannabis companies
See how Flow helps cannabis founders.
We speak founders' language and have great operational understanding of cannabis businesses.
Book an intro call - we'll look under the hood and recommend concrete next steps.
Fractional CFO
For founders who want to improve their FP&A functions, build an investor-ready financial model, and prepare for the next VC round.
Capital raising
For bootstrapped and already-VC-backed entrepreneurs who are looking to raise late stage venture or growth capital.
M&A
For category-leading technology companies who are exploring exit alternatives with either financial or strategic acquirers.
Key cannabis KPIs to track
Adjusted EBITDA margin, state presence, retail stores and the 280E tax burden are the metrics investors track in cannabis.
| KPI | Definition |
|---|---|
| Revenue | Top-line revenue. MSO leaders (Curaleaf, Trulieve, Verano and Cresco) sit at $700M-$1.5B. |
| Adjusted EBITDA margin | MSOs run 20-30%; LPs frequently negative or marginal; ancillary services 10-25%. |
| State presence | Number of US states where the MSO operates licensed cultivation or retail. Higher count correlates with broader optionality. |
| Retail stores | Owned or operated retail dispensaries. The principal scale metric for vertically integrated MSOs. |
| Gross margin | Cultivation 40-60%; branded products 50-65%; retail 45-55% depending on state. |
| 280E tax burden | US federal tax penalty (IRC Section 280E) prevents normal deductions. Cash effective tax rates of 60-80% are common; Schedule III rescheduling would dramatically reduce this. |
| Operating cash flow | Free cash flow generation. Pure-play cannabis has been cash-burning at most LPs; better-run MSOs are now FCF positive. |
Main cannabis players globally
The most active cannabis companies and category leaders globally.
| Company | HQ | Overview |
|---|---|---|
Curaleaf curaleaf.com |  New York | Largest US MSO by revenue (CSE: CURA, FSE: CURA). Operates in 17+ US states plus European expansion. |
Trulieve trulieve.com | Tallahassee | Florida-dominant US MSO (CSE: TRUL). Strong medical positioning; expanded into Arizona, Pennsylvania, Maryland and other adult-use states. |
Verano verano.com | Chicago | Major US MSO (CSE: VRNO). Operates in 13+ states with strong Illinois, Florida, New Jersey and Pennsylvania positioning. |
Cresco Labs crescolabs.com | Chicago | US MSO and parent of the Sunnyside retail brand (CSE: CL). The 2022 Columbia Care acquisition (collapsed in 2023) shaped recent strategy. |
Green Thumb Industries (GTI) gtigrows.com | Chicago | US MSO (CSE: GTII). Operates RISE retail brand and owns Dogwalkers, Beboe, Dr. Solomon's and incredibles brands. |
Tilray Brands tilray.com |  Leamington | Canadian LP plus US-listed cannabis and beverage company (NASDAQ: TLRY). Acquired several US craft beer brands from AB InBev in 2023 to diversify. |
Canopy Growth canopygrowth.com | Smiths Falls | Canadian LP (NASDAQ: CGC, TSX: WEED). Constellation Brands held large stake until pulling back in 2023; restructured Canopy USA strategy. |
Aurora Cannabis auroramj.com | Edmonton | Canadian LP (NASDAQ: ACB, TSX: ACB). Strong medical international focus (Germany, Australia, Poland and the UK) after pivoting away from Canadian recreational. |
Cookies cookies.co | Los Angeles | Premium cannabis brand and retail chain founded by Berner. Private; licenses brand across multiple states; expanding internationally into Canada, Germany, Thailand and Italy. |
Charlotte's Web charlottesweb.com | Denver | Largest US hemp-CBD brand (TSX: CWEB). Hemp-derived cannabidiol consumer products; struggled with category regulatory ambiguity. |
CFO-as-a-service without the overhead
Fractional CFO services priced for startups - senior operator, no permanent headcount.
Key cannabis market trends
DEA Schedule III rescheduling, SAFER Banking reform and state-level recreational expansion are reshaping cannabis right now.
DEA Schedule III rescheduling under review
DEA proposed moving cannabis from Schedule I to Schedule III in 2024; final rule under review since. Schedule III would dramatically reduce 280E tax burden and enable normal banking and research.
State-level recreational expansion
Ohio went recreational August 2024; Florida, Pennsylvania, New Hampshire and Nebraska are key open states. Federal action still constrains interstate commerce and capital markets.
SAFER Banking reform
SAFER Banking Act would allow cannabis businesses to access federally insured banking. Has passed the House multiple times but stalled in Senate. The principal regulatory unlock for sector capital costs.
German medical legalisation April 2024
Germany legalised adult possession and expanded medical cannabis access in April 2024. European medical cannabis market growing fast; Aurora, Tilray, Canopy Growth and Bedrocan are core beneficiaries.
Hemp-derived intoxicants regulatory tightening
Hemp-derived Delta-8 and Delta-9 THC products have proliferated under Farm Bill ambiguity. State-level restrictions tightening in 2024-25 (Tennessee, California, Florida and Virginia). Major regulatory inflection ahead.
MSO M&A consolidation
Cresco-Columbia Care deal collapsed 2023; Verano-Goodness Growth deal terminated. Strategic consolidation has paused pending federal rescheduling; PE remains the more active capital source for tier-2 MSOs.
Similar verticals to cannabis
Explore niches like alcohol, baby care, fashion & clothing and consumer electronics.
Explore other sectors
We know tech inside & out.
We live and breath tech - true understanding of how startups operate is fundamental at what we do.
Recent insights across cannabis and beyond
Talk to us
Schedule a call to get a health check on your business and see how we could help.
Fractional CFO
- Fractional CFO for Software
- Fractional CFO for AI & ML
- Fractional CFO for Fintech
- Fractional CFO for Consumer internet
- Fractional CFO for Digital media
- Fractional CFO for E-commerce & marketplaces
- Fractional CFO for Consumer products
- Fractional CFO for Mobility
- Fractional CFO for Digital health
- Fractional CFO for Industrial technology
- Fractional CFO for Digital infrastructure
- Fractional CFO for IT services
Stages
Countries
- UK Fractional CFO
- Ireland Fractional CFO
- France Fractional CFO
- Germany Fractional CFO
- Spain Fractional CFO
- Portugal Fractional CFO
- Italy Fractional CFO
- Netherlands Fractional CFO
- Belgium Fractional CFO
- Switzerland Fractional CFO
- Austria Fractional CFO
- Denmark Fractional CFO
- Sweden Fractional CFO
- Norway Fractional CFO
- Finland Fractional CFO
- Poland Fractional CFO
- Estonia Fractional CFO
- US Fractional CFO
- Canada Fractional CFO
- Mexico Fractional CFO
- Brazil Fractional CFO
- UAE Fractional CFO
- Australia Fractional CFO
Cities
- London Fractional CFO
- Dublin Fractional CFO
- Paris Fractional CFO
- Berlin Fractional CFO
- Madrid Fractional CFO
- Lisbon Fractional CFO
- Milan Fractional CFO
- Amsterdam Fractional CFO
- Brussels Fractional CFO
- Zurich Fractional CFO
- Vienna Fractional CFO
- Copenhagen Fractional CFO
- Stockholm Fractional CFO
- Oslo Fractional CFO
- Helsinki Fractional CFO
- Warsaw Fractional CFO
- Tallinn Fractional CFO
- New York Fractional CFO
- Toronto Fractional CFO
- Mexico City Fractional CFO
- São Paulo Fractional CFO
- Dubai Fractional CFO
- Sydney Fractional CFO